Initial Statement of Beneficial Ownership (Form 3)

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * Kohler Terry 2. Date of Event Requiring Statement (Month/Day/Year) 02/26/2026 3. Issuer Name and Ticker or Trading Symbol ADMA BIOLOGICS, INC. [ADMA] (Last) (First) (Middle) C/O ADMA BIOLOGICS, INC., 5800 PARK OF COMMERCE BLVD. NW 4. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) CFO and Treasurer 5. If Amendment, Date Original Filed (Month/Day/Year) (Street) BOCA RATON, FL 33487 6. Individual or Joint/Group Filing (Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5) Common Stock 58,019(1) D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	(2)	12/08/2035	Common Stock	91,166	$19.39	D

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Kohler Terry C/O ADMA BIOLOGICS, INC. 5800 PARK OF COMMERCE BLVD. NW BOCA RATON, FL 33487			CFO and Treasurer

Signatures

/s/ Terry Kohler, by Michael A. Goldstein as Attorney-in-fact		02/26/2026
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	On December 8, 2025 (the "Grant Date"), ADMA Biologics, Inc. granted the Reporting Person 58,019 restricted stock units ("RSUs"), which vest 25% on the one-year anniversary of the Grant Date and each annual anniversary of the Grant Date, over four years, subject to the Reporting Person's continued service as of the applicable vesting date, and which RSUs will be settled into common stock upon vesting.
(2)	These stock options were granted to the Reporting Person on the Grant Date, and will vest over four years with 25% vesting on the Grant Date and the remaining 75% vesting monthly in equal installments over the next three years subject to the Reporting Person's continued service as of the applicable vesting date.
Remarks: Exhibit 24 - Power of Attorney

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.